Title:
新規方法
Document Type and Number:
Japanese Patent JP6874028
Kind Code:
B2
Abstract:
The disclosure provides the use of particular substituted heterocycle fused gamma-carboline compounds as pharmaceuticals for the treatment of residual symptoms of psychosis or schizophrenia. The disclosure also provides novel long acting injectable formulations of particular substituted heterocycle fused gamma-carboline compounds and use of such long acting injectable formulations for the treatment of residual symptoms of psychosis or schizophrenia.
Inventors:
Kimberly Banover
Li Pong
Sharon Mates
Robert Davis
Lawrence Pee Wenogle
Li Pong
Sharon Mates
Robert Davis
Lawrence Pee Wenogle
Application Number:
JP2019016947A
Publication Date:
May 19, 2021
Filing Date:
February 01, 2019
Export Citation:
Assignee:
INTRA-CELLULAR THERAPIES, INC.
International Classes:
A61K31/4985; A61K9/08; A61K9/14; A61K9/50; A61K47/14; A61K47/34; A61K47/42; A61K47/44; A61P25/18
Domestic Patent References:
| JP2013525352A | ||||
| JP2012504150A |
Foreign References:
| WO2013155504A1 | ||||
| US20110318415 | ||||
| US20090104274 |
Attorney, Agent or Firm:
Michiko Matsutani
Yasushi Ochiai
Yasushi Ochiai